This week was a busy and active week within the stem cell industry, as evidenced by our coverage of stem cell markets below. I am excited to share with you.
Check it out and let me know what you think?
Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare
Bioquark Inc. and RegenerAge SAPI de CV will focus on translational therapeutic applications of a range of regenerative and rejuvenation based healthcare interventions, with the goal of reducing human degeneration, suffering, and death.
Philadelphia, PA, USA/ Mexico City, Mexico; JULY 19, 2016 – Bioquark, Inc., a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenative healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.
“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.” [Read more…]
Investing in Cures for Cancer: GE Poised to Lead Industrialization of Cell Therapy Industry with Acquisition of Biosafe Group SA
Acquisition further develops integrated cell therapy and regenerative medicine offering to enable development and patient access to innovative life-saving therapies
CHALFONT ST GILES, England; July 13, 2016 09:00 AM EST —(BUSINESS WIRE)–GE Healthcare has acquired Biosafe Group SA, a supplier of integrated cell bioprocessing systems for the rapidly growing cell therapy and regenerative medicine industry for an undisclosed sum. The acquisition of Biosafe expands GE Healthcare’s end-to-end ecosystem of products, solutions and services for our cell therapy customers, and expands GE’s technology reach to a number of new cell and therapy types. [Read more…]
NiCord® to Introduce Paradigm Shift to HSCT? Potential to Provide Transplantation Option To Nearly All In Need
Headquartered in Jerusalem, Israel, Gamida Cell is best known for its innovative approaches to hematopoietic stem cell therapeutics. Although a small company at the time, Gamida Cell broke onto the global scene in 2003 when it announced a Phase I trial of its StemEx™ product for the treatment of leukemia and lymphoma patients.
StemEx™ was Gamida Cell’s first generation product for theex vivo (“outside the body”) expansion of cord blood stem cells, which can be utilized in hematopoietic stem cell transplantation (HSCT) to treat high risk cancers. Although StemEx™ did not make it beyond Phase II/III trials, this expertise in ex vivo expansion of cord blood lead to the development of Gamida Cell’s current flagship product, NiCord®, and established Gamida Cell as a global technology leader for functional expansion of cells. [Read more…]
Two-Thirds of All Mesenchymal Stem Cell (MSC) Publications Were Released in the Past 5 Years
In an incredible finding, a search of the PubMed database for scientific publications containing the term “mesenchymal stem cell” or “mesenchymal stem cells” now returns nearly 30,000 results – 28,597 to be exact. (PubMed search of terms “mesenchymal stem cell” and “mesenchymal stem cells” executed July 15, 2016.)
Additionally, mesenchymal stem cell (MSC) scientific publications have increased in number EVERY year since 1992. That is 26 years in a row.
If those numbers haven’t shocked you, then this will” 17,804 of those MSC articles were released in the last 5 years (62%). Meaning, two-thirds of all MSC publications were published in the past 5 years, even though MSCs were discovered by Friedenstein and colleagues in 1976. [Read more…]
- « Previous Page
- 1
- …
- 285
- 286
- 287
- 288
- 289
- …
- 334
- Next Page »